Clobetasol Propionate Related Compound A is a synthetic byproduct arising from the esterification pathway of clobetasol, characterized by a hydroxyl substitution at the propionate side chain instead of the terminal ester group. This structural modification introduces a polar hydroxyl moiety, altering its physicochemical properties relative to the parent drug. The molecule retains the core glucocorticoid scaffold with a 6ฮฑ-fluoro-9ฮฑ-chloro-11ฮฒ-hydroxyandrostane backbone, conferring similar chromatographic behavior. It functions as an HPLC reference standard for quantifying process-related impurities in clobetasol formulations.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| EP | Y0000571 โ | 0.4 MG | EUR 90.00 |
| USP | 1138427 โ | 50 mg | USD 896.00 |
CCC1=C(C(=O)[C@@]2(O1)[C@H](C[C@@H]3[C@@]2(C[C@@H]([C@]4([C@H]3CCC5=CC(=O)C=C[C@@]54C)F)O)C)C)Cl
InChI=1S/C25H30ClFO4/c1-5-18-20(26)21(30)25(31-18)13(2)10-17-16-7-6-14-11-15(28)8-9-22(14,3)24(16,27)19(29)12-23(17,25)4/h8-9,11,13,16-17,19,29H,5-7,10,12H2,1-4H3/t13-,16-,17-,19-,22-,23-,24-,25-/m0/s1
LXZPFTQONPQBQD-TUZVJILZSA-N